Compass Therapeutics, Inc. (CMPX)

1.13 0.00 (0.00%) USD  |  NASDAQ  |  Sep 25, 16:00
1.14 +0.01 (+0.88%) After-Hours: 19:59
More

Compass Therapeutics Cash and Short Term Investments (Annual) : 208.91M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for CMPX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 208.91M
December 31, 2024 126.72M
December 31, 2023 152.46M
December 31, 2022 186.61M
Date Value
December 31, 2021 144.51M
December 31, 2020 47.08M
December 31, 2019 25.30M
December 31, 2018 57.51M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Viking Therapeutics, Inc. 705.74M
Capricor Therapeutics, Inc. 318.13M
Ardelyx, Inc. 264.69M
Biomea Fusion, Inc. 55.81M
ARS Pharmaceuticals, Inc. 244.99M